Complete remission of treatment-refractory advanced angiosarcoma of the scalp by protracted intralesional interleukin-2 therapy

Br J Dermatol. 2015 Apr;172(4):1156-8. doi: 10.1111/bjd.13400. Epub 2015 Feb 25.

Authors

C Gebhardt¹, B Ziegler, S Stadler, S Goerdt, J Utikal

Affiliation

¹ Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. c.gebhardt@dkfz.de.

PMID: 25204400
DOI: 10.1111/bjd.13400

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antineoplastic Agents / administration & dosage*
Drug Resistance, Neoplasm
Female
Head and Neck Neoplasms / drug therapy*
Hemangiosarcoma / drug therapy*
Humans
Injections, Intralesional
Interleukin-2 / administration & dosage*
Remission Induction
Scalp
Skin Neoplasms / drug therapy*

Substances

Antineoplastic Agents
Interleukin-2